APO-OLMESARTAN/AMLODIPINE 40/10 olmesartan medoxomil 40 mg and amlodipine (as besilate) 10 mg tablet blister pack

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

amlodipine besilate, Quantity: 13.87 mg; olmesartan medoxomil, Quantity: 40 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

amlodipine besilate,Olmesartan medoxomil

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: macrogol 8000; powdered cellulose; magnesium stearate; titanium dioxide; microcrystalline cellulose; croscarmellose sodium; polyvinyl alcohol; silicon dioxide; purified talc; iron oxide red

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Olmesartan and amlodipine combination tablets are indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination (see Dosage and administration).

Sommarju tal-prodott:

Visual Identification: Brownish red coloured, round shaped, biconvex, film coated tablets with "APO" engraved on one side and "40 over 10" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 18 Months; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2016-01-12